We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
226
DELISTED
Ansys
ANSS
| $47.1M | 0.09% |
117,423
+116,060
| +8,515% | +$44.6M |
|
227
Ametek
AME
$55.4B
| $47.1M | 0.09% |
+320,098
| New | +$43.8M |
|
|
DOCU
228
DocuSign
DOCU
$10.5B
| $46.9M | 0.09% |
307,652
+294,578
| +2,253% | +$67.2M |
|
229
Trip.com Group
TCOM
$29.6B
| $46.8M | 0.09% |
1,900,122
+1,810,401
| +2,018% | +$51.3M |
|
230
Frontdoor
FTDR
$5.1B
| $46.7M | 0.09% |
1,275,179
+1,200,313
| +1,603% | +$45.6M |
|
231
O'Reilly Automotive
ORLY
$72.9B
| $46.7M | 0.09% |
991,770
+772,770
| +353% | +$33.4M |
|
232
BHP
BHP
$215B
| $46.7M | 0.09% |
867,255
+139,952
| +19% | +$7M |
|
|
JWN
233
DELISTED
Nordstrom
JWN
| $46.7M | 0.09% |
2,064,012
+688,129
| +50% | +$18.2M |
|
234
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
| $46.7M | 0.09% |
536,500
+213,500
| +66% | +$18.5M |
|
235
EPAM Systems
EPAM
$5.51B
| $46.7M | 0.09% |
69,830
-10,709
| -13% | -$6.89M |
|
236
Zurn Elkay Water Solutions
ZWS
$8.38B
| $46.5M | 0.09% |
1,277,234
+1,264,292
| +9,769% | +$45.5M |
|
|
237
CALL
Apple
AAPL
$4.54T
| $46.4M | 0.09% |
+261,500
| New | +$41.3M |
|
|
P
238
Everpure Inc
P
$25.7B
| $46.1M | 0.09% |
1,417,574
+1,269,195
| +855% | +$36.8M |
|
|
EMBJ
239
Embraer S.A. ADS
EMBJ
$12.2B
| $45.7M | 0.08% |
+2,577,238
| New | +$41.7M |
|
240
Sarepta Therapeutics
SRPT
$1.57B
| $45.4M | 0.08% |
503,638
+500,289
| +14,938% | +$42.8M |
|
241
PNC Financial Services
PNC
$99.7B
| $45.3M | 0.08% |
225,873
+198,444
| +723% | +$40.4M |
|
242
Prudential Financial
PRU
$42.4B
| $45M | 0.08% |
415,911
+109,331
| +36% | +$11.9M |
|
|
GOOS
243
Canada Goose Holdings
GOOS
$872M
| $44.9M | 0.08% |
1,211,731
+1,205,631
| +19,764% | +$49.4M |
|
244
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.65B
| $44.3M | 0.08% |
462,500
-306,600
| -40% | -$31.4M |
|
245
PUT
Bank of America
BAC
$435B
| $43.7M | 0.08% |
+981,700
| New | +$44.7M |
|
246
NetEase
NTES
$85.3B
| $43.4M | 0.08% |
426,894
+214,764
| +101% | +$21.8M |
|
247
Motorola Solutions
MSI
$72.3B
| $43.4M | 0.08% |
+159,864
| New | +$40.3M |
|
248
CVS Health
CVS
$133B
| $43.4M | 0.08% |
420,853
+376,824
| +856% | +$34.8M |
|
249
BioNTech
BNTX
$22.9B
| $43.3M | 0.08% |
169,007
+166,367
| +6,302% | +$45.6M |
|
250
Gentex
GNTX
$4.97B
| $43.3M | 0.08% |
1,241,395
+1,175,976
| +1,798% | +$41.7M |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.